These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39348961)

  • 1. Inhibition of Epithelial-Mesenchymal Transition and Migration in Cisplatin-resistant Cancer Through Combined Treatment With Cisplatin and SH003.
    Choi HS; Ku JK; Ko SG; Yun PY
    Anticancer Res; 2024 Oct; 44(10):4359-4369. PubMed ID: 39348961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines.
    Choi HS; Kim YK; Yun PY
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
    Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis.
    Choi HS; Kim YK; Yun PY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells.
    Valinezhad Sani F; Palizban A; Mosaffa F; Jamialahmadi K
    Eur J Pharmacol; 2020 Feb; 868():172883. PubMed ID: 31866406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process.
    Hou L; Hou X; Wang L; Li Z; Xin B; Chen J; Gao X; Mu H
    Cancer Biomark; 2017 Dec; 21(1):187-194. PubMed ID: 29103028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH003 selectively induces p73‑dependent apoptosis in triple‑negative breast cancer cells.
    Choi EK; Kim SM; Hong SW; Moon JH; Shin JS; Kim JH; Hwang IY; Jung SA; Lee DH; Lee EY; Lee S; Kim H; Kim D; Kim YS; Choi YK; Kim HI; Choi HS; Cho SG; Kim JE; Kim KP; Hong YS; Lee WK; Lee JS; Kim TW; Ko SG; Jin DH
    Mol Med Rep; 2016 Oct; 14(4):3955-60. PubMed ID: 27599791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2.
    Xu G; Yu H; Shi X; Sun L; Zhou Q; Zheng D; Shi H; Li N; Zhang X; Shao G
    BMC Pulm Med; 2014 Nov; 14():174. PubMed ID: 25380840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
    Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
    Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
    Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
    Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.
    Jiang GB; Fang HY; Tao DY; Chen XP; Cao FL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3838-3846. PubMed ID: 31115011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
    Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
    Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro.
    Yang MD; Sun Y; Zhou WJ; Xie XZ; Zhou QM; Lu YY; Su SB
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines.
    Choi HS; Kim YK; Hwang KG; Yun PY
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crocin Combined with Cisplatin Regulates Proliferation, Apoptosis, and EMT of Gastric Cancer Cells via the FGFR3/MAPK/ERK Pathway
    Li Y; Guo QJ; Chen R; Zhao L; Cui X; Deng Y; Luo YS
    Curr Cancer Drug Targets; 2024; 24(8):835-845. PubMed ID: 37718528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide and tetraarsenic oxide induce cytotoxicity and have a synergistic effect with cisplatin in paclitaxel-resistant ovarian cancer cells.
    Byun JM; Lee DS; Landen CN; Kim DH; Kim YN; Lee KB; Sung MS; Park SG; Jeong DH
    Acta Oncol; 2019 Nov; 58(11):1594-1602. PubMed ID: 31257975
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased breast cancer cell sensitivity to cisplatin using a novel small molecule inhibitor.
    Hatzidaki E; Daikopoulou V; Apostolou P; Ntanovasilis DA; Papasotiriou I
    J Cancer Res Ther; 2020; 16(6):1393-1401. PubMed ID: 33342803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.